Infection with Alternate Frequencies of SARS-CoV-2 Vaccine Boosting for Patients Undergoing Antineoplastic Cancer Treatments

Researchers quantified reinfection risks for patients undergoing distinct antineoplastic therapies, given alternative frequencies of boosting with Pfizer-BioNTech BNT162b2.